NCT06676085View on ClinicalTrials.gov

A Novel Strategy of ECMO Management Using Nafamostat for Regional Combined With Low Intensity Systematic Anticoagulation

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
ECMO
Interventions
DRUG

Nafamostat

Nafamostat combined with unfractionated heparin for anticoagulation

DRUG

Heparin

unfractionated heparin for anticoagulation

Trial Locations (1)

100020

RECRUITING

Bing Sun, Beijing

All Listed Sponsors
lead

Beijing Chao Yang Hospital

OTHER